Skip to content

The Newest Obesity Drug May Also Combat Sleep Apnea

A Zepbound injection pen from Eli Lilly.
A Zepbound injection pen from Eli Lilly. Image: oleschwander (Shutterstock)

The newest weight loss drug on the market, Zepbound, might also help keep people’s snoring down. On Wednesday, Eli Lilly announced the preliminary results of two Phase III trials testing its drug tirzepatide for people with both obesity and obstructive sleep apnea. – Ed Cara Read More